Top

Published in:

01-02-2020 | Type 2 Diabetes | Original Article

Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes

Authors: Joyita Banerjee, Swagata Roy, Yogita Dhas, Neetu Mishra

Published in: Clinical and Experimental Medicine | Issue 1/2020

Abstract

Rapid urbanization and unhealthy dietary patterns critically increase the risk of type 2 diabetes (T2D) in middle-aged Indians. However, despite recent evidence of senescence-associated microRNAs (SA-miRNAs) in regulating complex pathways of ageing, their expressions in middle-aged Indians with T2D remain unexplored. Hence we aimed to investigate the changes in expressions of SA-miRNAs miR-34a and miR-126 in middle-aged T2D patients. A total of 30 T2D patients and 30 controls were recruited of age 31–50 years. The expressions of plasma miR-34a and miR-126 were determined by quantitative PCR. Oxidized LDL (OxLDL) and malondialdehyde (MDA) levels were quantified using enzyme-linked immunosorbent assay (ELISA). The effect of different glucose concentrations on miR-34a, miR-126, senescence-associated, and oxidative stress-responsive genes were also studied in an in vitro model of mice pancreatic β-cells. MiR-34a was significantly upregulated, whereas miR-126 was nonsignificantly reduced in T2D patients as compared to controls. T2D patients showed elevated levels of oxidative stress markers than controls. Analysis of cultured mice pancreatic β-cells exposed to high glucose showed significant upregulation of miR-34a, miR-126, p53, and superoxide dismutase 2 (SOD2). We found that circulating miR-34a levels and oxidative stress markers levels were elevated in the middle-aged Indians with T2D as compared to controls. The presence of diabetes may aggravate the normal ageing process in the middle-aged Indians. These SA-miRNAs can also be used to check the cellular dysfunctions and ageing of pancreatic β-cells.

Available only for authorised users

Anjana RM, Pradeepa R, Deepa M, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research–INdia DIABetes (ICMR–INDIAB) study. Diabetologia. 2011;54:3022–7. https://doi.org/10.1007/s00125-011-2291-5.CrossRefPubMed

Kumar KN, Katkuri S, Ramyacharitha I. A study to assess prevalence of diabetes mellitus and its associated risk factors among adult residents of rural Khammam. Int J Community Med Public Health. 2018;5:1360–5. https://doi.org/10.18203/2394-6040.ijcmph20180985.CrossRef

Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009;1:18–28. https://doi.org/10.1111/j.1753-0407.2008.00004.x.CrossRefPubMed

Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–81. https://doi.org/10.1001/jama.287.19.2570.CrossRefPubMed

He Z, King GL. Microvascular complications of diabetes. Endocrinol Metab Clin North Am. 2004;33:215–38. https://doi.org/10.1016/j.ecl.2003.12.003.CrossRefPubMed

Morley JE. Diabetes and aging: epidemiologic overview. Clin Geriatr Med. 2008;24:395–405. https://doi.org/10.1016/j.cger.2008.03.005.CrossRefPubMed

Mendoza-Núñez VM, Rosado-Pérez J, Santiago-Osorio E, et al. Aging linked to type 2 diabetes increases oxidative stress and chronic inflammation. Rejuvenation Res. 2011;14:25–31. https://doi.org/10.1089/rej.2010.1054.CrossRefPubMed

Sone H, Kagawa Y. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia. 2005;48:58–67. https://doi.org/10.1007/s00125-004-1605-2.CrossRefPubMed

Aguayo-Mazzucato C, van Haaren M, Mruk M, et al. β cell aging markers have heterogeneous distribution and are induced by insulin resistance. Cell Metab. 2017;25:898–910. https://doi.org/10.1016/j.cmet.2017.03.015.CrossRefPubMedPubMedCentral

10.

Aguayo-Mazzucato C, Andle J, Lee TB Jr, et al. Acceleration of β cell aging determines diabetes and senolysis improves disease outcomes. Cell Metab. 2019;30:129–142.e4. https://doi.org/10.1016/j.cmet.2019.05.006.CrossRefPubMedPubMedCentral

11.

Monickaraj F, Aravind S, Gokulakrishnan K, et al. Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem. 2012;365:343–50. https://doi.org/10.1007/s11010-012-1276-0.CrossRefPubMed

12.

Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol. 2013;9:513. https://doi.org/10.1038/nrendo.2013.86.CrossRefPubMed

13.

Banerjee J, Nema V, Dhas Y, et al. Role of microRNAs in type 2 diabetes and associated vascular complications. Biochimie. 2017;139:9–19. https://doi.org/10.1016/j.biochi.2017.05.007.CrossRefPubMed

14.

Kenyon CJ. The genetics of ageing. Nature. 2010;464:504. https://doi.org/10.1038/nature08980.CrossRefPubMed

15.

Liu FJ, Wen T, Liu L. MicroRNAs as a novel cellular senescence regulator. Ageing Res Rev. 2012;11:41–50. https://doi.org/10.1016/j.arr.2011.06.001.CrossRefPubMed

16.

Carnero A. Markers of cellular senescence. In: Galluzzi L, Vitale I, Kepp O, Kroemer G, editors. Cell Senescence Methods in Molecular Biology (Methods and Protocols) Humana Press. NJ: Totowa; 2013. p. 63–81.CrossRef

17.

Williams J, Smith F, Kumar S, et al. Are microRNAs true sensors of ageing and cellular senescence? Ageing Res Rev. 2017;35:350–63. https://doi.org/10.1016/j.arr.2016.11.008.CrossRefPubMed

18.

Olivieri F, Bonafè M, Spazzafumo L, et al. Age-and glycemia-related miR-126-3p levels in plasma and endothelial cells. Aging (Albany NY). 2014;6:771. https://doi.org/10.18632/aging.100693.CrossRef

19.

Fomison-Nurse I, Saw EEL, Gandhi S, et al. Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells. Cell Death Differ. 2018;25:1336–49. https://doi.org/10.1038/s41418-017-0047-6.CrossRefPubMedPubMedCentral

20.

Bommer GT, Gerin I, Feng Y, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol. 2007;17:1298–307. https://doi.org/10.1016/j.cub.2007.06.068.CrossRefPubMed

21.

Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 2007;26:5017. https://doi.org/10.1038/sj.onc.1210293.CrossRefPubMed

22.

Yamakuchi M. MicroRNA regulation of SIRT1. Front Physiol. 2012;3:68. https://doi.org/10.3389/fphys.2012.00068.CrossRefPubMedPubMedCentral

23.

Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1, and p53: the feedback loop. Cell Cycle. 2009;8:712–5. https://doi.org/10.4161/cc.8.5.7753.CrossRefPubMed

24.

Ito T, Yagi S, Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun. 2010;398:735–40. https://doi.org/10.1016/j.bbrc.2010.07.012.CrossRefPubMed

25.

Welten SMJ, Goossens EAC, Quax PHA, et al. The multifactorial nature of microRNAs in vascular remodelling. Cardiovasc Res. 2016;110:6–22. https://doi.org/10.1093/cvr/cvw039.CrossRefPubMed

26.

Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15:261–71. https://doi.org/10.1016/j.devcel.2008.07.002.CrossRefPubMedPubMedCentral

27.

Jansen F, Yang X, Hoelscher M, et al. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation. 2013;128:2026–38. https://doi.org/10.1161/CIRCULATIONAHA.113.001720.CrossRefPubMed

28.

Seyhan AA, Lopez YON, Xie H, et al. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep. 2016;6:31479. https://doi.org/10.1038/srep31479.CrossRefPubMedPubMedCentral

29.

Lawson R, Maret W, Hogstrand C. Prolonged stimulation of insulin release from MIN6 cells causes zinc depletion and loss of β-cell markers. J Trace Elem Med Biol. 2018;49:51–9. https://doi.org/10.1016/j.jtemb.2018.04.020.CrossRefPubMed

30.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method. Methods. 2001;25:402–8. https://doi.org/10.1006/meth.2001.1262.CrossRefPubMed

31.

American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017;40:S11–24. https://doi.org/10.2337/dc17-S005.CrossRef

32.

Banerjee J, Mishra N, Damle G, et al. Beyond LDL-c: the importance of serum oxidized LDL in predicting risk for type 2 diabetes in the middle-aged Asian Indians. Diabetes Metab Syndr: Clin Res Rev. 2019;13:206–13. https://doi.org/10.1016/j.dsx.2018.08.036.CrossRef

33.

Yamada A, Cox MA, Gaffney KA, et al. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia. PLoS ONE. 2014;9:e112481. https://doi.org/10.1371/journal.pone.0112481.CrossRefPubMedPubMedCentral

34.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.CrossRefPubMed

35.

Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. https://doi.org/10.1007/BF00280883.CrossRefPubMed

36.

Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Anal Biochem. 1966;16:359–64. https://doi.org/10.1016/0003-2697(66)90167-9.CrossRefPubMed

37.

Li X, Khanna A, Li N. Circulatory miR-34a as an RNA-based, noninvasive biomarker for brain aging. Aging (Albany NY). 2011;3:985. https://doi.org/10.18632/aging.100371.CrossRef

38.

Gwee Sian Khee S, Yusof M, Anum Y, et al. Expression of senescence-associated microRNAs and target genes in cellular aging and modulation by tocotrienol-rich fraction. Oxid Med Cell Longev. 2014;2014:725929. https://doi.org/10.1155/2014/725929.CrossRefPubMedCentral

39.

Navarro F, Lieberman J. miR-34 and p53: new insights into a complex functional relationship. PLoS ONE. 2015;10:e0132767. https://doi.org/10.1371/journal.pone.0132767.CrossRefPubMedPubMedCentral

40.

Lin X, Guan H, Huang Z, et al. Downregulation of Bcl-2 expression by miR-34a mediates palmitate-induced Min6 cells apoptosis. J Diabetes Res. 2014;2014:258695. https://doi.org/10.1155/2014/258695.CrossRefPubMedPubMedCentral

41.

Liu H, Jin M, Tian H, et al. MiR-34a and miR-34c are involved in the pathogenesis of type-2 diabetes by modulating the cell cycle of pancreatic beta-cell. Int J Clin Exp Pathol. 2016;9:5340–5.

42.

Lovis P, Roggli E, Laybutt DR, et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction. Diabetes. 2008. https://doi.org/10.2337/db07-1252.CrossRefPubMedPubMedCentral

43.

Liu Y, Gao G, Yang C, et al. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci. 2014;15:10567–77. https://doi.org/10.3390/ijms150610567.CrossRefPubMedPubMedCentral

44.

Pastukh N, Meerson A, Kalish D, et al. Serum miR-122 levels correlate with diabetic retinopathy. Clin Exp Med. 2019;19:255–60. https://doi.org/10.1007/s10238-019-00546-x.CrossRefPubMed

45.

Zhang J, Sun XJ, Chen JA, et al. Increasing the miR-126 expression in the peripheral blood of patients with diabetic foot ulcers treated with maggot debridement therapy. J Diabetes Complicat. 2017;31:241–4. https://doi.org/10.1016/j.jdiacomp.2016.07.026.CrossRef

46.

Meng S, Cao JT, Zhang B, et al. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol. 2012;53:64–72. https://doi.org/10.1016/j.yjmcc.2012.04.003.CrossRefPubMed

47.

Tao H, Wang MM, Zhang M, et al. MiR-126 suppresses the glucose-stimulated proliferation via IRS-2 in INS-1 β-cells. PLoS ONE. 2016;11:e0149954. https://doi.org/10.1371/journal.pone.0149954.CrossRefPubMedPubMedCentral

48.

Willette AA, Johnson SC, Birdsill AC, et al. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimer’s Dement. 2015;11:504–10. https://doi.org/10.1016/j.jalz.2014.03.011.CrossRef

49.

Burton DG, Faragher RG. Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing. Biogerontology. 2018;19:447–59. https://doi.org/10.1007/s10522-018-9763-7.CrossRefPubMedPubMedCentral

50.

Carracedo J, Merino A, Briceño C, et al. Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB J. 2011;25:1314–22. https://doi.org/10.1096/fj.10-173377.CrossRefPubMed

51.

Cheleschi S, De Palma A, Pascarelli NA, et al. Could oxidative stress regulate the expression of microRNA-146a and microRNA-34a in human osteoarthritic chondrocyte cultures? Int J Mol Sci. 2017;18:2660. https://doi.org/10.3390/ijms18122660.CrossRefPubMedCentral

52.

Blum A, Meerson A, Rohana H, et al. MicroRNA-423 may regulate diabetic vasculopathy. Clin Exp Med. 2019;17:1–9. https://doi.org/10.1007/s10238-019-00573-8.CrossRef

53.

Nagano T, Nakano M, Nakashima A, et al. Identification of cellular senescence-specific genes by comparative transcriptomics. Sci Rep. 2016;6:31758. https://doi.org/10.1038/srep31758.CrossRefPubMedPubMedCentral

54.

Luo X, Jiang X, Li J, et al. Insulin-like growth factor-1 attenuates oxidative stress-induced hepatocyte premature senescence in liver fibrogenesis via regulating nuclear p53–progerin interaction. Cell Death Dis. 2019;10:451. https://doi.org/10.1038/s41419-019-1670-6.CrossRefPubMedPubMedCentral

55.

Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci. 2011;108:5003–8. https://doi.org/10.1073/pnas.1019055108.CrossRefPubMedPubMedCentral

Title: Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes
Authors: Joyita Banerjee
Swagata Roy
Yogita Dhas
Neetu Mishra
Publication date: 01-02-2020
Publisher: Springer International Publishing
Keyword: Type 2 Diabetes
Published in: Clinical and Experimental Medicine / Issue 1/2020
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI: https://doi.org/10.1007/s10238-019-00593-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

The epithelial cadherin –160C/A polymorphism is associated with decreased risk of colorectal cancer: a case–control study

Correction to: Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis

The role of fibroblast activation protein in progression and development of osteosarcoma cells

Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study

Iron chelation therapy for myelodysplastic syndrome: a systematic review and meta-analysis

Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page